Biogen (BIIB)
(Delayed Data from NSDQ)
$236.72 USD
+2.59 (1.11%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $236.76 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Brokerage Reports
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 701 - 720 ( 803 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
We Anticipate Sharpened Focus into Areas of Core Competency; Maintain Buy and Revising PT to $360
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Approaches to Remyelination and Repair: Key Questions Coming out of ECTRIMS 2015
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Highlights from the Meeting on the Mesa: Looking Beyond Stem Cells in Regenerative Medicine
Provider: H.C. Wainwright & Co., Inc.
Analyst: BREIDENBACH M
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Part 3 of Our Alzheimer?s Series: Biogen?s Approach to Tau and Neuroinflammation
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Informing Therapeutic Strategies and Predicting Rates of Decline in Alzheimer?s Disease
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Our Focus Is on Alzheimer?s; Initiating with a Buy Rating and $380 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Jan 9
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D